Thioglycosides offer the advantage over O-glycosides to be resistant to hydrolysis. Based on initial evidence of this recognition ability for glycosyldisulfides by screening dynamic combinatorial libraries, we have now systematically studied dithiodigalactoside on a plant toxin (Viscum album agglutinin) and five human lectins (adhesion/growth-regulatory galectins with medical relevance e.g. in tumor progression and spread). Inhibition assays with surface-presented neoglycoprotein and in solution monitored by saturation transfer difference NMR spectroscopy, flanked by epitope mapping, as well as isothermal titration calorimetry revealed binding properties to VAA (Ka: 1560 ± 20 M−1). They were reflected by the structural model and the affinity on the level of toxin-exposed cells. In comparison, galectins were considerably less reactive, with intrafamily grading down to very minor reactivity for tandem-repeat-type galectins, as quantitated by radioassays for both domains of galectin-4. Model building indicated contact formation to be restricted to only one galactose moiety, in contrast to thiodigalactoside. The tested glycosyldisulfide exhibits selectivity between the plant toxin and the tested human lectins, and also between these proteins. Therefore, glycosyldisulfides have potential as chemical platform for inhibitor design.
硫糖苷在耐
水解方面相对于O-糖苷具有优势。基于初步证据,通过筛选动态组合库,我们对二
硫二半
乳糖苷在植物毒素(槲寄生凝集素)和五种人类凝集素(与医学相关的粘附/生长调节半
乳糖凝集素,例如在肿瘤进展和传播中的作用)进行了系统研究。通过对表面呈现的新型糖蛋白和溶液中的抑制测定,结合饱和转移差异NMR光谱、表位映射,以及等温滴定热量法,揭示了其与槲寄生凝集素(V
AA)的结合特性(Ka: 1560 ± 20 M−1)。这些特性通过结构模型以及在暴露于毒素的细胞
水平上的亲和力得到了体现。相比之下,半
乳糖凝集素的反应性明显较低,在同一家族中,其反应性逐渐降低,特别是对串联重复型半
乳糖凝集素的反应性几乎微乎其微,通过对半
乳糖凝集素-4的两个结构域进行放射测定来量化。模型构建表明,与二
硫二半
乳糖苷相比,接触形成仅限于一个半
乳糖基团。所测试的糖苷二
硫化物在植物毒素和所测试的人类凝集素之间,以及这些蛋白质之间展现出了选择性。因此,糖苷二
硫化物在
抑制剂设计方面具有作为
化学平台的潜力。